Skip to main content
. 2015 May 12;3(4):919–923. doi: 10.3892/mco.2015.565

Figure 3.

Figure 3.

(A) Kaplan-Meier overall survival (OS) and (B) disease-free survival (DFS) curves for breast cancer patients according to the expression level of microRNA-29b (miR-29b) in estrogen receptor (ER)-negative primary tumors. The difference in OS between the miR-29b low and high expression levels was significant (P=0.048).